RecruitingPhase 3NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Sponsor: Stemline Therapeutics, Inc.
Boston, MA · +173 more sites
1 recruiting breast cancer studies with a site in Danvers, MA.
Sponsor: Stemline Therapeutics, Inc.
Boston, MA · +173 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.